Back to MF Merit Financial Group, LLC

TXG

5 quarters

Position history for MFMerit Financial Group, LLC's holdings in 10x Genomics, Inc.

Yes. Merit Financial Group holds 40,696 shares of TXG (10x Genomics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 5,525 shares (+15.7%) from Q1 2026. Merit Financial Group has held TXG since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.6M

Current Shares

40,696

Total Value Change

+$1.2M

Total Shares Change

+6,379

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
40,696
+15.7%
$1.6M0.0%$38.34
29
2026-Q1
Increased
35,171
+4.9%
$746,6800.0%$21.23
26
2025-Q4
Decreased
33,533
-2.0%
$546,9230.0%$16.31
0
2025-Q3
Decreased
34,220
-0.3%
$400,0320.0%$11.69
0
2025-Q2
New
34,317
-
$397,3910.0%$11.58
33

Other major holders of TXG: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used